Indication
Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
Loading your page…
Loading your page…
Graft Rejection
Marketing Authorisation Holder: Chiesi Farmaceutici S.p.A.
EMA Authorisation: 18/07/2014
INN: tacrolimus
AI Drug & Interaction Analysis
Free account required
Ask Osler about Envarsus: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.